Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category

Cellular Senescence Assay Kit (ab253387)

Price and availability

179 581 ₸

Availability

Order now and get it on Tuesday March 09, 2021

Key features and details

  • Detection method: Colorimetric

You may also be interested in

Fingolimod (FTY720), S1P receptor modulator (ab142065)
Product image
Anti-CENPT antibody (ab86595)
Product image
Anti-Filaggrin antibody [SPM181] - BSA and Azide free (ab218863)
Product image
PE Anti-DcR1 antibody [003] (ab275730)

Overview

  • Product name

    Cellular Senescence Assay Kit
  • Detection method

    Colorimetric
  • Product overview

    Can be used to monitor and detect β-galactosidase activity in senescent cells at pH 6.0 using X-Gal.

    Many primary cell types, particularly fibroblast cells, have a limited capacity to reproduce in cell culture. Even normal cells, derived from fetal, embryonic or newborn tissue, typically undergo between 40 and 60 cell divisions, but then often stop dividing, becoming senescent. When cells become senescent changes in morphology and gene expression patterns occur. In addition, senescence is also accompanied by increases in acidic senescence-associated β-galactosidase (SA-ß-Gal). This activity can be monitored using the substrate 5-bromo-4-chloro-3-indolyl-β-galactopyranoside (X-Gal) at pH 6 and is a useful enzymatic marker of cellular senescence (SA-β-Gal). While cells entering senescence show this enzymatic activity, immortalized cell types, including tumor or other quiescent cells, are not stained under these conditions. The implications of these methods in such diverse areas as age-related pathology research, tumor analysis and tissue culture maintenance is significant. When β-Gal cleaves the glycosidic linkage in X-Gal, a soluble, colorless indoxyl derivative is produced, which quickly dimerizes and becomes oxidized to produce a bright blue indigo dye precipitate at the site of β-Gal activity. The dimerization and oxidation reaction is facilitated, in this kit, by a developer buffer solution containing ferric and ferrous ions. Senescent cells can be determined by examining the number of blue cells in the total cell population. The kit provides enough reagents and standards for up to 100 assays, using a microtiterplate method, and includes a detailed protocol for use in cultured mammalian cells.

    This kit is sold by Marker Gene under product code M1389.

Properties

  • Storage instructions

    Please refer to protocols.
  • Components 1 units
    DMF 1 x 2.5ml
    Fixing Solution 1 x 100ml
    Staining Buffer 1 x 50ml
    X-Gal Substrate 1 x 50mg

Images

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Clear all

Recently viewed products

  •  
  • Product image

    Anti-Sodium/Hydrogen Exchanger 1/NHE-1 antibody (ab230449)

  •  
  • Product image

    Anti-SCAMP2/SC2 antibody [EPR10185] - BSA and Azide free (ab249081)

  •  
  • Product image

    Anti-KDM5C / Jarid1C / SMCX antibody (ab264168)

  •  
  • Product image

    Anti-ERp57 antibody - C-terminal (ab192444)

  •  
  • Product image

    HRP Anti-TOMM20 antibody [EPR15581-39] - Mitochondrial Marker (ab205796)

  •  
  • Product image

    Anti-QSOX2 antibody - C-terminal (ab191168)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.